INFARMED hosted this Friday the seventh meeting under the scope of the Portuguese Presidency of the Council of the European Union. The event gathered over 80 participants of the Network of Competent Authorities on Pricing and Reimbursement (NCAPR), from all Member-States, the European Commission and OECD.
The meeting focused on the topic of Medicines Accessibility and the Sustainability of Health Systems. The participants shared knowledge and experiences on how to deal with those challenges.
INFARMED presented the main strategies it adopted in the last few years that address the issues. Similar presentations were made by Spain and Slovenia.
Other presentations on new emerging technologies experiences, namely single-use, were portrayed by the Netherlands, France, Sweden and Belgium, as well as the use of data to monitor the access to innovative medicines.
During the meeting the need to deepen the cooperation and collaboration between Member-States and its national authorities was highlighted, but also with the European Commission and OECD.
The Secretary of State for Health, Diogo Serras Lopes, addressed the participants at the start of the event to emphasise the need of the Member-States “to stay together” in order to “find the right mechanisms” and “define medium and long-term strategies” suitable to the promote access to healthcare.
The President of INFARMED, Rui Santos Ivo, also addressed the members to point out that the agenda of the meeting was aligned with the priorities for Health set by the Portuguese Presidency: promoting sustainable and equative access to medicine and medical devices.
The Network of Competent Authorities on Pricing and Reimbursement (NCAPR) is an informal co-operation platform created in 2008, in order to discuss issues and challenges in the field of pricing and reimbursement of medicines. NCAPR is aimed at bringing together policymakers and decision-makers to share their expertise, concerns and to explore common positions concerning current and future issues related to accessibility and the pricing and reimbursement of medicines.
The meeting is part of the set of 20 meetings of the several Committees and Working Groups that INFARMED will be holding during the next months of the Presidency.